Skip to main content
. 2022 Nov 30;9:986825. doi: 10.3389/fmed.2022.986825

FIGURE 1.

FIGURE 1

Kaempferol alleviated dysregulated UACR, BW, FBG and dyslipidemia levels of db/db mice. (A) Urine albumin-creatine ratio (UACR) (mg/g), (B) Body weight (g), (C) Fasting blood glucose (FBG) (mmol/L), (D) Total cholesterol (TC) (mmol/L), (E) Low density lipoprotein-cholesterol (LDL-C) (mmol/L), and (F) serum creatinine (SCr) (μmol/L) were measured after KPF treatment. The data were presented as the mean ± SD (n = 5, ##p < 0.01 vs. db/m mice; *p < 0.05 and **p < 0.01 vs. db/db mice; ns, not significant).